Puzzle Medical Devices, Inc., a Montreal, Canada-based developer of a transcatheter pump intended for chronic support, closed its first convertible debenture financing round of undisclosed amount.
The round was led by Canadian entrepreneur Pascal Labrecque with participation from a United States venture capital firm, entrepreneurs and interventional cardiologists practicing in Canada, the United States and Europe.
This investment follows the completion of Puzzle Medical’s first preclinical studies and will support the continued development towards clinical testing of a revolutionary transcatheter pump intended for chronic support.
Led by Stuart Kozlick, CEO, Puzzle Medical Devices is a company specializing in the development of a minimally invasive long-term hemodynamic transcatheter pump. To date, the company has completed acute in-vivo preclinical implantations with tremendous success.